cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Stockal+Disclaimer.pdf
8 own
6 watching
Current Price
$38.6
$-0.1
(-0.26%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
2,454.2M
52-Week High
52-Week High
71.85000
52-Week Low
52-Week Low
37.92000
Average Volume
Average Volume
0.48M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
201.9092
iconMarket Capitalization2,454.2M
icon52-Week High71.85000
icon52-Week Low37.92000
iconAverage Volume0.48M
iconDividend Yield--
iconP/E Ratio201.9092
What does the Stockal+Disclaimer.pdf do?
We are a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. Our initial product offering consists of two minimally-invasive, novel catheter-based mechanical thrombectomy devices. We purpose-built our products for the specific characteristics of the venous system and the treatment of the two distinct manifestations of venous thromboembolism, or VTE – deep vein thrombosis and pulmonary embolism. Our ClotTriever product is FDA-cleared for the removal of clot from peripheral blood vessels and is used to treat patients suffering from deep vein thrombosis, or DVT. We were formed under the laws of the state of Delaware in July 2011 under the name Inceptus Newco1 Inc. and changed our name to Inari Medical, Inc. in September 2013. Our principal executive offices are located at 9 Parker, Suite 100, Irvine, CA 92618 and our telephone number is (877) 923-4747. Our website address is www.inarimedical.com.
Read More
How much money does Stockal+Disclaimer.pdf make?
News & Events about Stockal+Disclaimer.pdf.
Ticker Report
10 months ago
Inari Medical, Inc. (NASDAQ:NARI Get Rating) CFO Mitch C. Hill sold 6,500 shares of Inari Medical stock in a transaction on Monday, June 12th. The shares were sold at an average price of $59.24, for a total value of $385,060.00. Following the completion of the sale, the chief financial ...
Zolmax
1 year ago
Inari Medical (NASDAQ:NARI Get Rating) and iCAD (NASDAQ:ICAD Get Rating) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, earnings, institutional ownership, analyst recommendations, risk, valuation and ...
Ticker Report
1 year ago
Inari Medical, Inc. (NASDAQ:NARI Get Rating) CEO Andrew Hykes sold 9,000 shares of Inari Medical stock in a transaction that occurred on Monday, March 20th. The shares were sold at an average price of $64.29, for a total transaction of $578,610.00. Following the completion of the transaction...
Globe Newswire
1 year ago
IRVINE, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (Inari) a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, announced positive results from the FLAME study in high-risk/massive pulmonary ...
Ticker Report
1 year ago
Inari Medical, Inc. (NASDAQ:NARI Get Rating) has been given an average rating of Moderate Buy by the ten analysts that are currently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and eight have assigned a ...
Frequently Asked Questions
Frequently Asked Questions
What is Stockal+Disclaimer.pdf share price today?
plus_minus_icon
Can Indians buy Stockal+Disclaimer.pdf shares?
plus_minus_icon
How can I buy Stockal+Disclaimer.pdf shares from India?
plus_minus_icon
Can Fractional shares of Stockal+Disclaimer.pdf be purchased?
plus_minus_icon
What are the documents required to start investing in Stockal+Disclaimer.pdf stocks?
plus_minus_icon
What is today’s traded volume of Stockal+Disclaimer.pdf?
plus_minus_icon
What is today’s market capitalisation of Stockal+Disclaimer.pdf?
plus_minus_icon
What is the 52-Week High and Low Range of Stockal+Disclaimer.pdf?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf down from its 52-Week High?
plus_minus_icon
What percentage is Stockal+Disclaimer.pdf up from its 52-Week Low?
plus_minus_icon
Current Price
$38.6
$-0.1
(-0.26%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00